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The analysis of illicit drugs in urban wastewater is the basis of
wastewater-based epidemiology (WBE), and has received much
scientific attention because the concentrations measured can be
used as a new non-intrusive tool to provide evidence-based and
real-time estimates of community-wide drug consumption. More-
over, WBE allows monitoring patterns and spatial and temporal
trends of drug use. Although information and expertise from other
disciplines is required to refine and effectively apply WBE,
analytical chemistry is the fundamental driver in this field. The use
of advanced analytical techniques, commonly based on combined
chromatography—mass spectrometry, is mandatory because the
very low analyte concentration and the complexity of samples (raw
wastewater) make quantification and identification/confirmation of
illicit drug biomarkers (IDBs) troublesome. We review the most-
recent literature available (mostly from the last 5 years) on the
determination of IDBs in wastewater with particular emphasis on
the different analytical strategies applied. The predominance of
liquid chromatography coupled to tandem mass spectrometry to
quantify target IDBs and the essence to produce reliable and
comparable results is illustrated. Accordingly, the importance to
perform inter-laboratory exercises and the need to analyze
appropriate quality controls in each sample sequence is
highlighted. Other crucial steps in WBE, such as sample collection
and sample pre-treatment, are briefly and carefully discussed. The
article further focuses on the potential of high-resolution mass
spectrometry. Different approaches for target and non-target
analysis are discussed, and the interest to perform experiments
under laboratory-controlled conditions, as a complementary tool to
investigate related compounds (e.g.3, minor metabolites and/or
transformation products in wastewater) is treated. The article ends
up with the trends and future perspectives in this field from the
authors’ point of view. # 2016 The Authors. Mass Spectrometry
Reviews Published by Wiley Periodicals, Inc. Mass Spec Rev
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I. INTRODUCTION
Illicit drug use is a global problem with severe consequences,
not only for people’s health and welfare, but also as a clear threat
to the stability and security of entire regions and economic and
social development. Accordingly, there is a considerable finan-
cial cost related to illicit drug use, associated with drug use
prevention, treatment of addicts, and on the fight against
organized crime (Nutt et al., 2007; EMCDDA, 2012; UNODC,
2014). Policy makers need accurate and reliable information on
the use of these substances in order to make evidence-based
decisions and to effectively allocate resources. The prevalence
of illicit drug use has traditionally been estimated with direct
subjective methods, like general population surveys and inter-
views, and indirect methods such as monitor drug-related
criminality, seizures, and hospital records (EMCDDA, 2015a).
Despite considerable improvements with modern communica-
tion facilities, and the use of complementary methods such as
targeted studies and statistical modeling, these survey methods
mainly rely on the willingness of users to self-report and to
monitor actions. However, the social taboo related to illicit drug
use might provoke non-participation and false responses in such
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surveys that makes these methods vulnerable and potentially
inaccurate. In addition, a common challenge with such methods
is that they are time-consuming, expensive, and complex
(Banta-Green & Field, 2011). Therefore, the development of
new and complementary approaches is encouraged in order to
obtain objective, low-cost, fast, reliable, and comparable data.
The chemical analysis of illicit drug residues in untreated
wastewater is as a valuable tool to complement existing
approaches to monitor spatiotemporal patterns and trends of
illicit drug use in large communities (Zuccato et al., 2008;
Thomas et al., 2012; Ort et al., 2014c; EMCDDA, 2015b). This
approach is termed wastewater-based epidemiology (WBE), and
relies on the principle that illicit drugs consumed by individuals
are excreted, either unchanged or as a mixture of metabolites,
into urban sewer networks. The quantitative measurement of
these specific illicit drug biomarkers (IDBs) in wastewater
samples reflects the drugs collectively excreted by users and
enables data to be gathered on drug use by the community within
the geographical boundary defined by the catchment area of a
wastewater treatment plant (WWTP). Several crucial steps are
involved in this approach (Fig. 1), which requires significant
expertise from numerous research fields, and therefore, strong
multi-disciplinary collaboration (Ort et al., 2014a).
The WBE concept was initially proposed by Daughton in
2001 (Daughton, 2001) and first applied in 2005 through the
estimation of cocaine use in Italy (Zuccato et al., 2005). Since
then, WBE has expanded to include other illicit drugs, such as
heroin, cannabis, and amphetamine-like stimulants (van Nuijs
et al., 2011; Castiglioni et al., 2014; EMCDDA, 2015b) and new
psychoactive substances (NPS) (Reid, Derry, & Thomas, 2014;
van Nuijs et al., 2014; Kinyua et al., 2015). Data have also been
reported for WBE-based analysis of alcohol (Reid et al., 2011;
Mastroianni, Lopez de Alda, & Barcelo, 2014; Rodrı´guez-Alvarez
et al., 2014, 2015; Boogaerts et al., 2016), tobacco (Rodrı´guez-
Alvarez et al., 2014; Castiglioni et al., 2015; Tscharke, White, &
Gerber, 2016), and counterfeit medicines (Venhuis et al., 2014).
An important step in the progression of WBE was accom-
plished with the establishment of a European-wide network
(Sewage analysis CORe group Europe [SCORE]), supported by
the European Monitoring Centre for Drug and Drug Addiction
(EMCDDA, 2015b). This network has since 2010 standardized the
WBE approach, coordinated international studies (Thomas et al.,
2012; Ort et al., 2014c), and conducted inter-laboratory exercises
for quality control purposes. The latter provided a means to
estimate and critically assess the uncertainty related to the
wastewater-based estimates (Castiglioni et al., 2013). However,
important WBE research has also been conducted in other
continents such as Asia (Lai et al., 2013b; Khan et al., 2014; Li
et al., 2014; Kim et al., 2015), Australia (Irvine et al., 2011;
Prichard et al., 2012; Lai et al., 2013a; Tscharke et al., 2015,
2016), North America (Banta-Green et al., 2009; Burgard et al.,
2013; Subedi & Kannan, 2014), and Central and South America
(Maldaner et al., 2012; Devault et al., 2014; Voloshenko-Rossin
et al., 2015; Bijlsma et al., 2016). Furthermore, a recently
published review on neuropsychiatric pharmaceuticals and illicit
drugs in WWTPs (Asimakopoulos & Kannan, 2016) is recom-
mended for readers interested.
The increasing interest of WBE is clearly illustrated by the
number of papers and citations on the topic (>200 papers in
years 2005–2015, >5000 citations; ISI Web of Science),
international conferences and workshops organized on this
topic, and funding received from the European Commission
(“http://score-cost.eu/”; “http://sewprof-itn.eu/”).
Chemical analysis of IDBs in wastewater plays an important
key role within the WBE approach. Advanced analytical techniques
and expertise is required to obtain accurate concentration data on
IDBs in wastewater, because quantitative data are the basis of
subsequent back-calculations of IDB mass loads and drug use.
Concentrations of IDBs in wastewater samples are generally around
a factor 1000 lower than in human biological fluids (ng/L vs. ng/
mL), which points out the challenge for quantitative analysis. Low
analyte concentrations in combination with the complexity and
unknown composition of the wastewater matrix might hamper not
only the sensitive and accurate quantification but also a sound
identification. Chromatography—mass spectrometry is the best-
suited approach to obtain the sensitivity, selectivity, and identifica-
tion requirements in chemical analysis directed toward WBE.
Gas chromatography coupled to mass spectrometry
(GC-MS) (Mari et al., 2009; Gonzalez-Mari~no et al., 2010) in
general provides high levels of selectivity and sensitivity.
However, derivatization of the target compounds is often
necessary for most IDBs in order to make them compatible with
GC. Consequently, sample treatment and measurement is
generally laborious and time-consuming. Liquid chromatogra-
phy coupled to mass spectrometry (LC-MS) is a more-versatile
technique that allows the determination of polar, low-volatility,
and/or thermolabile compounds, which most IDBs are, with less
sample treatment and shorter chromatographic analysis times.
Besides, the sample matrix (i.e., water) is completely compati-
ble with this technique. LC—tandem mass spectrometry
(LC-MS/MS), for example, a triple quadrupole (QqQ) analyzer,
is even more powerful, and has become the technique of choice
for the quantitative determination of (known) IDBs in wastewa-
ter samples (van Nuijs et al., 2011).
Despite the predominance of LC-MS/MS in WBE studies,
the use of high-resolution mass spectrometry (HRMS) has been
recently explored and opens new perspectives in the analytical
field. Its strong potential to screen and for identification
purposes originates from the acquisition of accurate-mass full-
spectrum data. LC-HRMS is a powerful technique that allows
the wide-scope screening of many illicit drugs, metabolites and
transformation products, as well as the investigation of NPS
(Bijlsma et al., 2013b; Hernandez et al., 2014; Iba~nez et al.,
2014; Reid et al., 2014; Alechaga, Moyano, & Galceran, 2015;
Bade et al., 2015c; Baz-Lomba, Reid, & Thomas, 2016). There
are several illustrative examples (as presented later in this
FIGURE 1. Main consecutive steps of the WBE approach and data required
for each step (modified from Castiglioni et al. (2014)).
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manuscript) in the most-recent literature that show that modern
analytical chemistry is essential in order to increase our
knowledge on trends in substance use in the general population.
In this article, an exhaustive review of the existing literature
is not the goal. Rather, the objective is to present an overview of
the approach by using the most-recent literature available, with
specific emphasis on the different analytical strategies applied
for WBE. Most cited papers have been published within the last
5 years, except for some that have also been included because of
their relevance in the development of the WBE approach. The
predominance of LC-MS/MS to quantify priority, well-known,
target IDBs and the essence to produce reliable and comparable
results are illustrated. Accordingly, the importance to perform
inter-laboratory exercises and the need to analyze appropriate
quality controls in each sample sequence is highlighted. Other
crucial steps related to WBE, such as sample collection and
sample pre-treatment, are discussed. The article further focuses
on novel analytical approaches, such as enantiomeric profiling,
the different strategies for target and non-target analysis with
LC-HRMS, and on the interest to perform in vivo or in vitro
metabolism experiments and degradation laboratory experi-
ments, as a useful tool to investigate metabolites and transforma-
tion products in wastewater. The article concludes with the
trends and future perspectives in this discipline from the authors’
point of view.
II. TARGET AND NON-TARGET APPROACHES
The terms target and non-target analyses are widely employed in
analytical chemistry. Other expressions, such as investigation of
unknowns or suspect screening, are also frequently used, and
illustrate the analytical challenges in complex fields, such as
environmental analytical chemistry (Krauss, Singer, & Hollender,
2010; Schymanski et al., 2014b; Bletsou et al., 2015). With
the implementation of LC-HRMS in several analytical fields, the
term post-target analysis has been also employed, and illustrate
the working mode in which full-spectrum accurate-mass techni-
ques are applied (Hernandez et al., 2005). Clarification of these
terms is, however, necessary to fully understand the different
strategies that can be applied to investigate the presence of IDBs
in wastewater samples.
Target methodologies are commonly analyte-dependent;
that is, compound-specific information is required before
measurement. Based on this analyte-specific information,
highly sensitive and selective analytical methods can be
developed, but other compounds that might be present in the
samples will remain undetected. Target analysis is typically
applied in methods based on LC and/or GC coupled to MS
(Selected Ion Monitoring [SIM] mode) or tandem MS
(Selected Reaction Monitoring [SRM] mode). A limited list
of target compounds is included in the scope of the method,
and only those previously selected ions/transitions are
monitored. Reliable identification and quantification is
commonly the main objective pursued in this type of
analysis. This identification is achieved through acquisition
of at least three ions in the SIM mode or two MS/MS
transitions in the SRM mode, and evaluation of retention
time (tR) and ion-intensity ratios (SANTE/11945, 2015). The
use of reference standards is compulsory with this methodol-
ogy in order to optimize the mass spectrometric measure-
ment parameters and for quantitative method validation.
This methodology can also be applied with HRMS instru-
ments. However, thanks to the accurate-mass full-spectrum
acquisition at good sensitivity, HRMS offers the possibility to
investigate the presence of many other compounds, not only
those initially targeted. Databases developed in-house are
commonly used to facilitate screening of a large number of
compounds with HRMS. The information included in the
database depends on the availability of a reference standard.
When available, the information is very complete (i.e., tR, exact
mass of the (de)protonated molecule and/or adducts, and the
main fragment ions) to highly facilitate the analytical research.
When the reference standard is not available, only limited
information on the target analytes can be included in the
database (e.g., molecular formula and exact mass, theoretical
isotope distribution, predicted tR). Information reported in the
literature on product ions can also be taken into account to
facilitate compound identification. Even in this worst-case
situation (i.e., when no standard is available), accurate-mass
full-spectrum data can be used for the tentative identification of
the compounds in samples (Hernandez et al., 2015a), a process
where the interpretation and justification of the fragment ions
observed is crucial. In any case, the fact that a search is directed
toward a list of compounds implies a target approach, indepen-
dent of the availability of reference standards. This target
approach is commonly known as suspect screening (Krauss,
Singer, & Hollender, 2010; Hug et al., 2014) whereas other
authors use the term post-target (Hernandez et al., 2005; Iba~nez
et al., 2008).
Target analysis based on HRMS commonly detects and
identifies the compounds (i.e., qualitative analysis) in wastewa-
ter, because HRMS really takes advantage of its excellent
performance for this type of application (Hernandez et al.,
2011a, 2014). However, recent studies have also been directed
toward the quantitative analysis of IDBs in wastewater
(Gonzalez-Mari~no et al., 2012; Bijlsma et al., 2013b; Fedorova
et al., 2013; van der Aa et al., 2013; Heuett et al., 2015), and a
notable increase in the number of quantitative applications of
HRMS that pursue a complete analysis (i.e., sensitive detection,
reliable identification, accurate quantification) is expected in the
near future.
A significant advantage of full-spectrum acquisitions is that
they also allow the investigation of any other compound, not
only the list of selected contaminants, in a non-target methodol-
ogy. In contrast to the (post-) target approach, a genuine non-
target analysis does not use any previous information on the
compounds to be searched in the samples. Some authors use the
term non-target screening when they search for unknowns,
which in a strict sense starts without any information on the
compounds to be investigated. The term unknown does not
necessarily mean that the compound discovered in the analysis
is a new or an unreported compound. Following the elucidation
processes, the unknownmight turn out to be a known compound,
which already has been reported in the literature, but unexpected
or not specifically searched for in the samples. In a genuine non-
target analysis, there is no analyte selection a priori (neither
before nor after MS acquisition). Under these circumstances,
compound identification at trace levels in wastewater is a
challenge, and commonly more than one elemental formula and
several plausible structures are obtained for a given unknown
detected in a sample (Iba~nez et al., 2008; Krauss, Singer, &
Hollender, 2010; Schymanski et al., 2014a). More information
260 Mass Spectrometry Reviews DOI 10.1002/mas
& HERNANDEZ ET AL.
on non-target analysis applied in the environmental field can be
found elsewhere (Hogenboom, van Leerdam, & de Voogt, 2009;
Chiaia-Hernandez et al., 2014; Hug et al., 2014; Schymanski
et al., 2014b, 2015; van Leerdam et al., 2014).
Most IDBs are of (medium) high polarity; therefore,
LC-HRMS commonly uses TOF and Orbitrap analyzers. The
absence of standardized mass spectral libraries in LC-MS is an
additional difficulty in non-target analysis, opposite to GC-MS
with electron ionization (EI), where the availability of commer-
cial libraries (e.g., NIST) offers the possibility to identify
compounds by matching experimental and library spectra.
In order to have a more-realistic and complete overview on
the presence of organic contaminants in general, and on IDBs in
particular, a combination of target (both with or without stand-
ards (i.e., suspect screening) and non-target methodologies
seems to be the most-attractive approach (Hug et al., 2014).
Furthermore, the combination of GC-HRMS and LC-HRMS
(e.g., use the same QTOF instrument for both configurations)
moves toward a more-comprehensive screening of organic
contaminants in the aquatic environment independently of their
polarity and volatility (Hernandez et al., 2015b).
III. SAMPLE COLLECTION APPROACHES AND
SAMPLE PREPARATION
Measurements with high-end instruments and sophisticated
statistical analysis cannot compensate or reveal deficiencies in
sample collection. Depending on the desired level of representa-
tiveness and accuracy, sample collection is as important as any
subsequent steps. A sound understanding of the investigated
environment is imperative and must be documented in detail.
For most applications in WBE, the end user relies on 24-hr
composite influent (i.e., raw) wastewater samples collected
routinely at the inlet of a WWTP. We briefly outline how such a
sample is ideally collected (sampling) and how many samples
are needed (monitoring) for specific applications.
A. Sampling
The number of consumers of a specific substance, pharmacoki-
netics, the population connected to a WWTP, and the hydraulic
properties of the sewer system determine: (i) the number of
toilet flushes that contain the substance of interest, and (ii) over
which period an individual toilet flush expands when it passes
the sampling location. These two factors determine the temporal
variability on the scale of minutes, which in turn determines the
required sampling frequency to collect a representative sample
(i.e., how many samples must be collected and pooled over a
certain period for analysis). Due to the potentially small number
of relevant toilet flushes—at least for one of multiple substances
analyzed in the collected sample—it is recommended that
sampling intervals do not exceed 5–10min at the influent of
large WWTPs. Even shorter sampling intervals of 1–5min are
necessary for composite samples from effluents of individual
premises. At the effluent of, for example, a prison, the toilet
flushes extend over shorter periods and the absolute number of
substance-related flushes is typically much smaller than at the
influent of a (large) WWTP, both leading to a substance pattern
that fluctuates much more at the scale of a few minutes. This is
also applicable to influents of very small WWTPs, where it may
be beneficial to sample from the effluent of a primary treatment
tank, which attenuates temporal fluctuations to some extent.
However, please note that the latter also removes some particu-
late matter and that WWTP-internal recirculation may influence
mass loads there. Shorter sampling intervals are also required
for the collection of representative samples that extend over
periods <24 hr, for example, hourly composite samples to
reliably assess diurnal variations. Please note, grab samples to
determine diurnal variations are not suitable because of potential
high short-term variations. In addition, intra-day variations in
wastewater flows require samples to be collected in a flow- or
volume-weighted manner. More details and peculiarities for
wastewater sampling in sewers, an overview of relevant
literature, and a list of requirements for a series of typical
applications is described elsewhere (De Keyser et al., 2010; Ort
et al., 2010a,b; Ort, 2014; Coutu et al., 2016).
B. Monitoring
Ideally, one would analyze 365 daily composite samples per
year. Due to limited resources, this amount of samples is usually
not feasible. Different (research/epidemiological) questions
require different monitoring designs, and obviously more
samples provide higher accuracy. Random day-to-day variabil-
ity, systematic weekly cycles, and seasonal fluctuations influ-
ence baseline variation. Together with the desired level of
sensitivity and significance, the baseline variation determines
the required number and distribution of samples. To date,
two monitoring design studies have investigated different
approaches that aim to answer different questions. They are
based on a few available long-term time series; that is, data sets
with observations over more than 28 consecutive days. In brief,
it was found that the baseline variation of almost all investigated
drug residues in five different catchments (population sizes that
range from approx. 7000 to 1.3 million people) did not exceed
80% (as coefficient of variation), not accounting for any
temporal correlation (EMCDDA, 2016). Based on these data,
Ort et al. (2014b) proposed that 56 stratified random samples (10
working days and 4 weekend days per quarter) are suitable to
estimate an annual mean with an accuracy of 10%. Humphries
et al. (2016) evaluated more informed approaches, which rely on
knowledge about weekly cycles. In the presence of strong
weekly cycles (e.g., cocaine or MDMA), it is efficient to
distribute monitoring days systematically by considering peak,
mid, and through usage days. The identification of weekly cycles
requires an intensive, monitoring period. In return, the accuracy,
particularly of intra-annual trends, improves the informed
routine monitoring compared to an uninformed scheme with the
same reduced number of samples. In the context to assess effects
of interventions, the baseline variation, the magnitude of the
effect to be shown, and the confidence level determine the
number of required samples.
C. Collection of (Meta)Information
An example of a questionnaire to collect (meta)information
relevant to evaluate the appropriateness of sampling and to
facilitate the interpretation of results is can be found (Ort
et al., 2014c). This paper encompasses catchment properties
(e.g., hydraulic residence time, population size, and how it
was estimated), as well as details on sample collection and
handling.
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D. Stability of IDs Biomarkers in the Samples Under
Storage Conditions
It is often not possible to immediately analyse samples for the
presence of IDBs. It is, therefore, necessary to store wastewater
samples until analysis under conditions that avoid transforma-
tion of the analytes, because biotransformation during storage
would lead to false interpretations of WBE data, even if
analytical methods are accurate.
For most IDBs, experiments have been performed to
evaluate stability for different storage conditions, including
various temperatures, pH values, and preservation agent
additions, and for different time frames (reviewed in detail by
McCall et al., (2016)). Storage of wastewater samples at
20˚C ensures stability of most IDBs for at least 3 weeks.
For some IDBs (i.e., the amphetamine-type stimulants and 11-
nor-9-carboxy-delta-9-tetrahydrocannabinol [THC-COOH]),
experiments have revealed that they are even stable at
20˚C for more than 15 weeks (McCall et al., 2016). Stability
is ensured for only several days at 4˚C, whereas other IDBs
(e.g., cocaine) are within several hours transformed at this
temperature (McCall et al., 2016).
Acidification of the samples increases stability of the
majority of IDBs, but significantly enhances biotransformation
of THC-COOH. Because multi-analyte determinations are often
applied in WBE studies, it is, therefore, not advisable to acidify
the samples before storage. The effect of the addition of
preservation agents such as sodium metabisulfite (Na2S2O5) has
also been studied, and revealed higher stability for cocaine and
its metabolite benzoylecgonine (McCall et al., 2016). However,
for the other IDBs, more experiments need to be performed in
order to evaluate the efficacy to add preservation agents to
wastewater samples for storage purposes.
E. Sample Treatment
In order to remove solid particles from the wastewater samples,
two strategies can be followed: (i) a filtration step with
membrane of glass fiber filters with pore sizes as low as 0.1mm,
or (ii) a centrifugation step. In addition, because concentrations
of most IDBs in wastewater are in the ng/L–mg/L range, a
preconcentration step is generally required prior to analysis in
order to achieve the necessary quantification limits. However,
some modern analytical instruments allow direct injection of
filtered or centrifuged wastewater due to the high sensitivity
provided (Chiaia, Banta-green, & Field, 2008; Berset, Bren-
neisen, & Mathieu, 2010; Bisceglia et al., 2010; Lai et al., 2011;
Boix et al., 2015).
A sample-preparation step is commonly needed not only to
preconcentrate analytes, but also to remove matrix components
that might interfere with the analytical measurement (e.g.,
ionization suppression/enhancement processes in LC–MS) of
IDBs.
By far, the most-used procedure reported in the literature is
off-line solid-phase extraction (SPE) with sample volumes
between 50 and 1000mL (van Nuijs et al., 2011). Popular SPE
sorbents used for a reproducible extraction of IDBs from
wastewater are based on a polymeric backbone with reversed-
phase or cation-exchange properties. Some methods demon-
strated that off-line SPE sample preparation could also be
incorporated in a fully automated on-line SPE application that is
directly linked to the LC-MS analysis (Postigo, Lopez de Alda,
& Barcelo, 2008; Fedorova et al., 2013; Heuett et al., 2015).
Some alternative ways of sample preparation can be found
in the literature. Gonzalez-Mari~no et al. (2009) applied commer-
cially available molecular imprinted polymers (MIPs) to extract
and concentrate amphetamine-type stimulants from wastewater,
and reported better performance of the MIPs in terms of
selectivity, sensitivity, accuracy, and precision compared to off-
line SPE. The main drawbacks of this approach were no
possibility for multi-class analysis, and higher analysis time and
cost. The usefulness of solid-phase micro extraction (SPME) for
sample preparation to analyze amphetamine-type stimulants or
THC-COOH in wastewater has been demonstrated (Racamonde
et al., 2012, 2013). SPME is highly compatible with GC-MS,
and shows good performance; however, the main drawback was
the limited applicability to determinate multi-class compounds,
which is desired for WBE purposes.
IV. APPLICATIONS OF LOW-RESOLUTION MASS
SPECTROMETRY
Low-resolution MS systems, with either ion trap or QqQ
analyzers, are the most widely applied for the quantitative
determination of IDBs in wastewater. These MS systems
typically operate in the MS/MS mode, where one or more
product ions are monitored by selecting appropriate precursor-
to-product ion transitions (i.e., SRM). Even with this approach,
there are some probabilities that other compounds, not related to
the analyte, can share the same transition. Therefore, at least two
transitions is required to be monitored, and the presence of a
compound is considered to be confirmed if both transitions
produce a chromatographic peak at the same retention time, that
corresponds to that of the injection of a reference standard.
Identity confirmation is of the utmost importance because it
gives the required confidence to the reported results and reduces
the likelihood of reporting false positives. The confirmation of
identity is especially relevant when analyzing highly contami-
nated and complex matrices such as influent wastewater
samples. For confirmation, not only the acquisition of several
transitions is needed, but also the compliance of the ion ratio
between reference standards and samples. This important aspect
is discussed in more detail in section VII “Relevant analytical
parameters and quality control.”
Although ion-trap analyzers have been used in this field
(Bones, Thomas, & Paull, 2007; Gheorghe et al., 2008; Postigo,
Lopez de Alda, & Barcelo, 2008; Martı´nez-Bueno et al., 2011),
LC-MS/MS with QqQ has become the most-popular technique
due to its excellent performance in terms of robustness, dynamic
range, sensitivity, and selectivity. These characteristics, together
with the compatibility of LC-MS/MS with aqueous samples and
mostly polar analytes targeted in WBE studies, allow one to
notably simplify sample treatment. LC-MS/MS with QqQ can
nowadays be considered as the workhorse in analytical laborato-
ries that deal with WBE. This fact has also been illustrated in
monitoring studies of illicit drugs in wastewater, where the
majority of laboratories applied this technique (Castiglioni
et al., 2008; Thomas et al., 2012; Ort et al., 2014c).
Some of the early studies, used only one transition for
quantification (Chiaia, Banta-green, & Field, 2008; Gheorghe
et al., 2008; Bartelt-Hunt et al., 2009; Metcalfe et al., 2010).
However, it is nowadays widely accepted that confirmation of
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analyte identity in LC-MS/MS-based methodologies requires a
minimum of two transitions (European Commission, 2002). Yet,
the acquisition of more transitions per compound would
obviously give more confidence to the confirmation process, and
is feasible with the latest analytical instruments with faster
acquisition times (Boleda, Galceran, & Ventura, 2007; Bijlsma
et al., 2009, 2014a). The limited fragmentation in ESI,
frequently with low-abundance secondary and tertiary transi-
tions, can limit the absolute number of useful MRM transitions
for identification in some particular cases. Nevertheless, with
the excellent sensitivity of the new instruments, the acquisition
of, at least, two transitions is commonly not a problem. Typically
the most-abundant transition is selected to favor quantification
at low concentrations (quantifier, Q), and the other ones are
acquired for confirmation (qualifier, q). At this point, it is also
important to understand the fragmentation pattern of the
analytes under experimental conditions to allow selection of
analyte-specific fragments in order to minimize potential
interferences of the matrix and/or background noise. Hence, it
might occur that the most-sensitive transition presents more
matrix interference and/or background noise, and might there-
fore not be the most appropriate for quantification. As an
example, THC-COOH, a metabolite of the active ingredient
found in cannabis, was measured in the positive electrospray
ionization (ESI) mode. In this mode, the transition m/z
345> 327 is occasionally selected for quantification (Table 1).
However, this transition corresponds to a non-specific loss of
water, which might be more prone to interferences when
analyzing complex matrices, such as wastewater (Pozo et al.,
2006). This fact is demonstrated in Figure 2, where three
different transitions were acquired to measure THC-COOH in
influent wastewater. The transitions 345> 327 and 345> 299,
corresponding to losses of H2O and HCOOH, respectively,
presented higher noise than the less-abundant, but more-
selective, transition 345> 193. These matrix interferences has
also been observed in the negative mode; when a non-specific
loss of CO2 (343> 299) was measured.
Table 1 shows the quantification (Q) and confirmation (q)
transitions used during the monitoring campaign 2015 coordi-
nated by SCORE to measure the most widely studied IDBs in
influent wastewater in WBE research. In general, the Q
transition is, in most studies, the same with few exceptions.
However, more differences are observed in the qualifier transi-
tion used for confirmation.
The Q-transitions selected for cocaine and its metabolite
benzoylecgonine (BE) are in practically all cases 304> 182 and
290> 168, respectively. Both correspond to the neutral loss of
benzoic acid, specific for cocaine and its metabolites (Castiglioni
et al., 2008; Bijlsma et al., 2011). In relation to the q-transition,
some differences were observed, but 304> 82 and 290> 105
were most frequently selected. The Q- and q-transitions for
amphetamine are in most cases 136> 91 and 136> 119, and for
methamphetamine, 150> 91 and 150> 119, respectively. More
variation occurs in the selection of transitions for MDMA,
although most laboratories use 194> 163 for quantification.
THC-COOH has been measured in the negative- and
positive-ESI modes. Obviously, different transitions/ions are
selected in each case. The determination of THC-COOH is more
problematic than other drugs investigated. The use of different
ionization modes, the poorer sensitivity for this compound, and
the matrix interferences that affect LC–MS/MS analysis make
its determination more troublesome (Vazquez-Roig, Blasco, &
Pico, 2013; Bijlsma et al., 2014b; Ort et al., 2014c). Moreover,
other non-instrumental factors, such as possible sorption to
solids (Harman, Reid, & Thomas, 2011), in-sewer and in-sample
stability (McCall et al., 2016), might also play an important role
in the difficulty to get satisfactory results for this compound.
Although some difficulties might be related to its different
physico-chemical properties (lower polarity) compared with
other illicit drugs and metabolites, an unambiguous explanation
has not yet been found. The problems associated to the
determination of THC-COOH have been corroborated with
the results of inter-laboratory exercises, where data for this
compound indicate that recoveries of spiked amounts of
THC-COOH to wastewater invariably are low; those data
suggest a systematic underestimation of the true concentrations
of THC-COOH in this type of matrix.
The examples, shown above, illustrate that the selection of
appropriate transitions is not a banal aspect, and it requires a
detailed study before, considering not only the abundance of the
ions (used as common criterion), but also specificity and
associated issues such as background noise.
V. APPLICATIONS OF HIGH-RESOLUTION MASS
SPECTROMETRY
HRMS is a powerful technique with many different applications
in the investigation of IDBs in wastewater, from the screening of
large number of compounds, the elucidation of unknowns, the
identification of new metabolites and degradation/transforma-
tion products (TPs), to quantification of target analytes at low
concentrations. Several reviews have been published on the use
of HRMS to determine of licit and illicit drugs in environmental
analysis, and are recommended for those researchers interested
in this field (Wong & MacLeod, 2009; Petrovic et al., 2010;
Farre et al., 2012; Hernandez et al., 2012, 2014; Vazquez-Roig,
Blasco, & Pico, 2013; Kaufmann, 2014).
A. Wide-Scope Screening
HRMS allows the efficient screening of a large variety of
compounds, including IDBs, in wastewater. Its potential comes
from the acquisition of accurate-mass full-spectrum data
(Kaufmann et al., 2010). These data allow one to screen of
compounds in a post-target way without the need to pre-select
the analytes for method development, as stated in previous
sections. Furthermore, the presence of compounds initially not
considered, such as new substances and metabolites/TPs, can be
also investigated from data acquired in a retrospective way
without the need for additional analysis (Hernandez et al.,
2011a; Bijlsma et al., 2013b). This ability is advantageous,
because in some occasions, samples might already have been
discarded or the analytes are degraded, so additional sample
injections might not be possible. In this way, the screening can
be further widened by reprocessing raw data without the need to
perform new analysis.
The most-used HRMS analyzers are undoubtedly TOF and
Orbitrap. Both instruments can be efficiently coupled with LC,
although TOFMS has the advantage of easy coupling with ultra-
high performance liquid chromatography (UHPLC). On the
contrary, restrictions due to the lower scan speed can limit the
applicability of coupling an Orbitrap with UHPLC (Hernandez
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et al., 2014). As a consequence of the intrinsic characteristics of
these analyzers, the use of LC-HRMS enables screening for a
large number of IDBs at satisfactory sensitivity within one
analysis. Obviously, the restrictions derived from the chro-
matographic and ionization processes and from sample pre-
treatment have to be taken into account in a search for
contaminants. TOF analyzers have been widely used to screen
licit and illicit drugs, and their potential has been well-
documented (Hernandez et al., 2011a, 2014). Mass resolution
typically ranges from 20,000 up to recently 80,000 FWHM,
whereas mass accuracy <2 ppm and quantitative linear ranges
start to become usual. Following the invention by Makarov
(Hardman & Makarov, 2003; Hu et al., 2005; Makarov et al.,
2006), the Orbitrap has gained popularity in the investigation of
emerging contaminants (de Voogt et al., 2011; Fedorova et al.,
2013). An Orbitrap possesses high mass resolution (>100,000
FWHM), high mass accuracy (<5 ppm) and acceptable dynamic
range (5  103). The newest instruments can reach up to 450,000
FWHM at m/z 200 and sub-ppm mass accuracy. However, the
main drawback is its scanning speed, which is inverse to mass
resolution. Thus, a compromise between achievable resolution
and adequate chromatography must be found (Kellmann et al.,
2009; Makarov & Scigelova, 2010).
Hybrid configurations increase the potential of these
analyzers for screening purposes. The most-common are Q-TOF
and LIT-Orbitrap, although other possibilities exist, such as IT-
TOF and Q-Orbitrap. These hybrid instruments provide relevant
structural information by obtaining accurate-mass product-ion
spectra after MS/MS experiments. Information obtained with
MS/MS is highly useful to confirm potential positives revealed
by, for example, HRMS or QqQ analysis, and to elucidate
structures of unknowns or suspect compounds. However, the
pre-selection of the precursor ion is required for MS/MS
product-ion generation, and, therefore, a second injection is in
principle needed. In order to overcome these limitations,
product-ion spectra can be collected with data-dependent
acquisition (DDA). In this mode, the first scan usually works as
the survey scan, where data are processed “on-the-fly” to search
TABLE 1. SRM transitions most often used with LC-QqQ-MS instruments to determine IDBs in wastewater during the monitoring
campaign 2015 of SCORE (“http://score-cost.eu/”).
Note: More-detailed information regarding the analytical procedures can be found elsewhere: (Castiglioni et al., 2006; Postigo, Lopez de Alda, &
Barcelo, 2008; van Nuijs et al., 2009; Berset et al., 2010; Karolak et al., 2010; Lai et al., 2011; Fedorova et al., 2013; Senta et al., 2013; Andres-Costa
et al., 2014; Bijlsma et al., 2014a; Borova et al., 2014; Devault et al., 2014; Kankaanp€a€a et al., 2014; Tscharke et al., 2015; Castrignano, Lubben,
& Kasprzyk-Hordern, 2016). It is noteworthy that not all analytical methodologies used during the monitoring campaign were published.
aNumber of laboratories that selected the SRM transition (Q) for quantification/the total of laboratories that used LRMS and determine the IBD.
bNumber of laboratories that selected the SRM transition (q) for confirmation/the total of laboratories that selected the same Q-transition (see alsoa).
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for potential compounds of interest based on predefined selec-
tion criteria; for example, intensity threshold or a suspect
inclusion list. If the selection criteria are met or the included ion
is observed, then a second MS/MS scan (data-dependent) is
performed. The major advantage of this approach is the
collection of “clean” structural information in just one injection.
The main limitations are the intensity threshold itself, as well as
the size of the inclusion list (number of suspects searched); both
can negatively affect the achievable duty cycle. Hence, a
decrease in the number of data points (i.e., the number of scans),
affects the detectability of chromatographic peaks.
Advantageously, most current instruments also allow the
acquisition of full-scan spectra at different collision energies in
just one injection. As a function of the instrument and/or
manufacturer, this operation mode for the QTOF analyzer is
known as MSE (Castro-Perez et al., 2002; Plumb et al., 2006;
Dı´az et al., 2011; Hernandez et al., 2011a) in the case of Waters,
broadband collision-induced dissociation (bbCID) (Dasenaki
et al., 2015) in the case of Bruker, or all-ions MS/MS (Kinyua
et al., 2015) in the case of Agilent. Likewise for Q-Orbitrap
instruments from Thermo, this type of acquisition is also
possible, and known as All Ion Fragmentation (AIF) (Coscolla
et al., 2014; Berendsen et al., 2015), or variable Data-Indepen-
dent Analysis (vDIA) (Zomer & Mol, 2015). These approaches
are possible thanks to the availability of collision gas inside the
collision cell of the hybrid instruments. With the application of
low energy in the collision cell, fragmentation is minimized, and
the information obtained corresponds normally to the parent
molecule ((de)protonated and/or adducts in some cases). At high
collision energy, fragmentation of the molecule is favored. In
addition, the high-energy function provides not only fragmenta-
tion spectra similar to MS/MS experiments, but also the isotopic
pattern of the fragments, and it conserves adduct and/or dimer
information as the quadrupole works as an ion guide. In this
way, (de)protonated molecule and fragment ion data collection
are both enabled in a single acquisition without the need to
select the precursor ion; therefore, not affecting negatively the
duty cycle.
One of the main difficulties in wide-scope screening is to
ensure that the method can detect and identify all compounds
included in the target list. Reference standards are obviously
required for a final confirmation of the identity, but also needed
to perform method validation. Qualitative validation of the
screening is a key aspect, but a laborious and time-consuming
task. The objective is to ensure that the method detects a given
compound at an established minimum concentration; therefore,
the screening detection limit (SDL) is the main parameter
evaluated. To this aim, water samples spiked at different levels
need to be tested to establish the SDL as the lowest analyte
concentration tested that can be detected (wiht the most
abundant ion; that is, normally the (de)protonated molecule). In
absence of guidelines in the environmental field, the approach
used in other fields, such as pesticide residue analysis (SANCO,
2013) or doping control analysis (Pozo et al., 2007) can be
adopted. To accept the empirical value of SDL, it is necessary to
have at least 95% of positive detections in the spiked samples
FIGURE 2. Selectivity of THC-COOH transitions.
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tested. Another key parameter is the limit of identification; that
is, the lowest concentration tested for which the compound can
be detected (only one ion) and identified (at least two accurate-
mass ions, with acceptable mass errors). For identification, other
parameters have to be also considered, such as retention time
and ion-ratios (see below).
Qualitative validation is normally performed with selected
compounds from the target list that are taken as a model, due to
the extreme difficulties to validate the method for the huge
number of compounds that might be included in the target list.
Once the methodology is validated, the screening is applied to
sample analysis. The occurrence of false positives is drastically
minimized if strict criteria are applied for identification on the
basis of the accurate-mass data; however, one cannot ignore the
possibility of false negatives for those compounds that were not
previously validated.
Although the qualitative potential of HRMS is evident,
quantitative applications have been more limited until now,
mainly because HRMS analyzers typically show lower sensitiv-
ity and narrower dynamic range than QqQ instruments that
operate in SRM mode. Thus, most research until now has been
focused on identification and elucidation purposes. However,
Orbitrap and the latest TOF instruments show improved perfor-
mance to prompt their use also for quantification of IDBs in
wastewater (Gonzalez-Mari~no et al., 2012; Bijlsma et al.,
2013b).
The strategy used for HRMS screening strongly depends on
the availability of reference standards, as described previously.
Nevertheless, when dealing with thousands of compounds, it is
almost impossible to have all reference standards in the
laboratory. One of the main benefits with HRMS is that
reference standards are not strictly required in a first step of the
process, because a tentative identification of suspect compounds
can be made on the basis of the obtained information. Obviously,
reference standards highly facilitate the analytical task in the
screening, and are required for ultimate and unambiguous
confirmation (Fig. 3); however, they may be acquired only in a
final stage when solid well-founded evidence exists on the
presence of the compound in the sample. In this way, laborato-
ries do not need to acquire all reference standards before
analysis, with the subsequent problems of availability (e.g.,
TPs), costs, and expiry dates (Iba~nez et al., 2014).
In the absence of reference standards, HRMS data might be
sufficient for a tentative identification (Fig. 3). An example,
identification of 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrroli
dine (EDDP), a metabolite of methadone, in wastewater by
LC-QTOF MS, is shown in Figure 4. By combining the
information obtained in the low-energy (LE) function on the
protonated molecule and in the high-energy (HE) function on
the fragment ions, tentative identification of this metabolite was
feasible without any reference standard. The use of UHPLC also
facilitated the assignment of the chromatographic peaks that
corresponded to this compound (note that some ions present in
the HE spectra did not correspond to EDDP; marked as x in
the figure).
Successful identification depends on the quality of the
information provided (e.g., more than one accurate-mass is
required, low mass errors give more confidence to the process)
and on the knowledge of mass spectrometry fragmentation rules
to properly justify the fragment ions observed. Previous data
reported in the literature on fragment ions (in nominal and
accurate mass), which can also be available in databases such as
MassBank (Horai et al., 2010; “http://www.massbank.jp/”), are
useful to the analyst. Another interesting tool is retention-time
prediction, which helps to discard potential false positives and to
focus the elucidation process on only those peaks that fit the
predicted tR. These tR predictors are based on quantitative
structure-retention relationships (QSRRs) that vary from very
simple, which incorporate a single descriptor (Kern et al., 2009;
Bade et al., 2015b), to more complex, which use a large number
FIGURE 3. (Post)-target screening strategy.
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of descriptors (Miller et al., 2013; Bade et al., 2015a; Gago-
Ferrero et al., 2015; Munro et al., 2015; Barron and McEneff,
2016); however, all of these predictors are based on a single
column, commonly a reversed phase (C18) column. A direct-
mapping technique (PredRet) able to predict retention times
across different chromatographic systems has also recently been
developed (Stanstrup, Neumann, & Vrhovsek, 2015), but is
limited to compounds having to be within the PredRet database.
Although this area is rapidly advancing, the principal limitation
is the use of a single column for most predictions, with further
optimization needed for a truly transferable prediction
technique.
One of the issues that still remains without broad consensus
is the criteria applied for confident identification/confirmation. It
is clear that a combination of parameters is required for this aim,
including retention time and MS data. Accurate-mass measure-
ments give more confidence for a reliable identification than
nominal mass data, and this factor is recognized in several
guidelines, which, for example, give more identification points
to HRMS ions than LRMS ions (European Commission, 2002).
In addition, the ion intensity ratio is commonly used as a key
parameter in the identification process. It is widely accepted that
at least two accurate-mass ions are required for a confident
identification with HRMS. However, two main issues need to be
considered: (i) what is the acceptable mass error? (ii) what is the
maximum deviation acceptable in the ion ratio? Moreover,
another parameter helpful in the process is the isotopic distribu-
tion, especially when abundant isotope ions such as chlorine,
sulphur, or bromine are present. Several situations might occur
that lead to different degrees of confidence in identification. For
example, Schymanski et al. (2014a) propose up to 5 levels of
confidence in a non-target analysis. These levels range from
only exact mass to unequivocal molecular formula, and then
tentative candidate(s) followed by probable structure to a fully
confirmed structure with a reference standard.
Figure 5 summarizes the key parameters in the detection
and identification of a compound with HRMS. As shown in this
figure, different scenarios might occur as a function on the
information provided, and on the availability of reference
standard (Bade et al., 2015c; Hernandez et al., 2015a; Nacher-
Mestre et al., 2016).
When a reference standard is available, compounds can
be detected or identified. Detection is considered satisfactory
when the most-abundant ion (Q), commonly the (de)
protonated molecule, is found at the expected tR (0.1min,)
and mass error <5 ppm (SANTE/11945, 2015). Another
likely situation for detection is to find two representative
ions (i.e., the most-abundant ion (Q) and a fragment/adduct
ions(q) at the expected tR), but with mass errors between 5
and 20 ppm. The latter situation seems to occur when the
signal intensity is low (favored at low analyte concentra-
tions). In that case, an additional effort is recommended to
FIGURE 4. Tentative identification of EDDP, a methadone metabolite. (A) LE mass spectrum (bottom) HE mass
spectrum (top). (B) XICs of the protonated molecule and several fragment ions (X indicates that the fragment ion
is not related to EDDP).
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investigate more accurate-mass ions and/or repeat sample
injection. Identification is based on the presence of at least
two representative ions (Q, q) at the expected tR with mass
errors <5 ppm. Additionally, q/Q ratios should fit with those
for reference standards within tolerance limits (SANTE/
11945, 2015). Identification under these conditions is highly
reliable and can be considered as the ideal situation.
When the reference standard is not available, a tentative
identification can be made when an expected ion with mass error
<5 ppm is observed, together with its characteristic isotopic
pattern. Subsequently, the fragment ions should be evaluated by
comparing the data with, for example, data reported in the
literature or justified by the accurate-mass fragments taking into
account the structure of the molecule. However, for structure
confirmation, injection of the reference standard is eventually
required.
B. Non-Target Analysis
Full-spectrum accurate-mass acquisition provided with HRMS
also opens the possibility to investigate non-target compounds
in water (Iba~nez et al., 2005; Krauss, Singer, & Hollender, 2010;
Hernandez et al., 2011b; Dı´az et al., 2012; Hug et al., 2014;
Schymanski et al., 2015). A true “unbiased” non-target screen-
ing, without any a priori information on the compounds to be
detected, is an analytical challenge. This process needs exper-
tise, and is complex and time-consuming. The main difficulties
associated with this process when applied to environmental or
wastewater samples come from: (i) the complexity and unknown
composition of the sample that is investigated, (ii) the presence
of many peaks in the total ion chromatogram with the most-
abundant corresponding commonly to compounds other than the
analytes, and (iii) the low analyte concentrations. Thus, the main
problem is to prioritize the most “relevant” chromatographic
peaks in the sample, because the majority will not be associated
to drugs, in order to focus the subsequent elucidation process on
those compounds. From the HRMS information, a complex
process has to be applied that establishes the empirical formula
of the unknown compound, searches chemical databases for
potential candidates, and finally assigns the chemical structure
of the discovered compound.
In a true non-target analysis, the maximum number of
compounds from very different physico-chemical character-
istics should be investigated. Therefore, a combination of
GC-HRMS and LC-HRMS seems to be the most-appropriate
way to achieve this aim. Due to the complementarity of these
two techniques this approach can be seen as the most-
comprehensive to advance toward the desired “universal”
screening (Hernandez et al., 2015b). Obviously, some “difficult”
compounds would not likely be included in a wide-scope
screening. For example, very polar/ionic analytes would require
specific chromatographic separation (e.g., HILIC). Thus, a
combination of C18 and HILIC chromatographic columns
would render a wider scope for LC-amenable compounds. It
must be taken also into account that universality of the screening
should not refer only to the techniques of measurement but also
to the sample treatment. From this point of view, a generic
extraction, or even better, direct analysis of samples into the MS
system, would be the best option to avoid compound losses
during sample manipulation.
FIGURE 5. Detection and identification criteria in screening of illicit drugs with HRMS (modified from Nacher-
Mestre et al. (2016)).
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Because no pre-selection of analytes is made in non-target
analysis, the compounds discovered in water samples might
belong to the illicit drugs group, but also to any other family of
organic contaminants or their metabolites. The fact that most
IDBs are of medium to high polarity makes LC-HRMS the
most-attractive approach for their potential identification. How-
ever, the absence of standardized mass spectral libraries in
LC-MS is an additional difficulty in non-target analysis.
Advances in the creation of mass spectra libraries for LC-MS/
MS analysis will be of help in the near future, but at the moment
the analyst does not count on the aid of standardized libraries to
facilitate a non-target analysis.
An intermediate situation between target and true non-
target analysis is the application of “biased” non-target
approaches, where, for example, the formation of “unknown”
metabolites/TPs from a given parent compound is investigated
with “in vitro” or “in vivo” experiments, degradation laboratory
experiments, or in-silico models (Reid et al., 2014). Hence, the
investigation is focused on chemically related compounds (e.g.,
share a common fragment, moiety, or mass defect) or on
compounds that have specific atoms in their structure that give a
distinctive isotopic signature (e.g., Cl, Br, S). Here, the number
of chemically meaningful structures, which can be assigned to
an unknown peak, is limited to structures that show a close
relationship with the parent compound (Krauss, Singer, &
Hollender, 2010). This issue will briefly be treated in the
following section.
C. Investigation of Metabolites and Transformation
Products
The investigation of metabolites and TPs of illicit drugs in water
samples is a current topic of research (Bletsou et al., 2015).
WBE is based on the analysis of key biomarkers of drugs. These
IDBs can be the parent compound and/or the major urinary
metabolite(s). For the most known and widely consumed drugs,
information on human metabolism is already available, and has
allowed establishment of benzoylecgonine as the main metabo-
lite and IDB of cocaine, THC-COOH as main metabolite and
IDB of cannabis, or that methamphetamine, amphetamine, and
MDMA are mainly excreted as unchanged compounds. How-
ever, this information is usually scarce for NPS and, therefore,
the main biomarker of use is generally not well-established.
Although WBE is solely based on the measurement of
appropriate metabolites that result from human excretion
(commonly the major and most-stable ones), there is also a
concern about the presence of many other metabolites and TPs
of illicit and licit drugs in the aquatic environment. Especially,
possible long-term (chronic) effects on organisms and effects of
combined exposure to multiple compounds is of concern (van
der Aa et al., 2013). The detection and identification of these
compounds is a challenge for environmental analytical chemists,
and different approaches can be followed to this aim. In the case
of known metabolites and TPs, already reported in the literature,
an inclusion list of target analytes can be made. From an
analytical point of view, they can be treated similarly to their
parent compound with the above-mentioned target methodolo-
gies. Furthermore, retrospective analysis is also feasible by
reviewing the acquired MS data. For example, metabolites of
drugs have been retrospectively investigated in wastewater
samples previously analyzed for parent compounds only. In this
way, several metabolites were tentatively identified without the
need of additional analysis, and illustrate the potential of HRMS
in this field (Hernandez et al., 2011a; Bijlsma et al., 2013b).
Regarding unknown metabolites and TPs, the use of
common fragmentation pathways between the parent compound
and metabolites/TPs might discover new/unexpected com-
pounds. In this strategy, a common behavior in their fragmenta-
tion is assumed. The presence of additional chromatographic
peaks at the accurate masses of the fragments might reveal the
presence of analyte-related compounds. The accurate-mass
spectra and appropriate study of the fragmentation might finally
allow the (tentative) identification of metabolites/TPs (Thurman
et al., 2005; Garcı´a-Reyes, Molina-Dı´az, & Fernandez-Alba,
2007; Hernandez et al., 2011b). This approach can be extended
based not only on the fragmentation pathway of the parent
compound, but also on that of metabolites/TPs detected in
samples (Hernandez et al., 2009).
A simpler approach is prediction of possible metabolites or
TPs with computational (in silico) prediction tools (Reid et al.,
2014; Kirchmair et al., 2015). Many different methodologies to
predict metabolites or sites of metabolism have been reported
recently. The metabolic fate of a molecule depends on its
chemical reactivity toward metabolic processes that can occur,
as well as on its interactions (affinity and binding orientation)
with the biotransformation enzymes involved. The prediction
system should, therefore, properly be selected after consider-
ation of the organism or the system where metabolites/TPs are
formed. Commercially available and freely accessible programs
have been applied in this prediction step. Kirchmair et al.
(2015), reviewed 10 different software for predicting metabo-
lites, but only two are without costs and an additional one is
solely available for academia (Kirchmair et al., 2015). This free-
availability is probably the main reason that the University
of Minnesota Pathway Prediction System (UM-PPS: (“http://
eawag-bbd.ethz.ch/”) is one of the most-common prediction
tools in suspect metabolite/TPs screening (Kern et al., 2009).
Prediction of metabolites/TPs is followed by HRMS analy-
sis; the exact mass for each of the predicted compound is
extracted from the chromatogram and checked by a comparison
with control samples. The plausibility of the chromatographic
tR, isotopic pattern, and ionization efficiency are used as further
filters to narrow down the number of candidate peaks. The
structures of suspected compounds are tentatively identified
based on the observed fragmentation pattern.
A suitable strategy to investigate metabolites and TPs
makes use of “in vitro” or “in vivo” metabolism experiments,
and of laboratory or field-degradation experiments under
controlled conditions, which can identify known and unknown
metabolites or TPs of selected drugs, respectively. In the recent
literature, several examples can be found that deal with the
investigation of drug metabolites with in vitro or in vivo
experiments (Pozo et al., 2014; Takayama et al., 2014; Holm
et al., 2015; Meyer et al., 2015; Iba~nez et al., 2016). These
experiments are very useful and allow the discovery of
metabolites, which might be expected and detected in wastewa-
ter, and are, therefore, potential target IDBs in future WBE-
based studies. The discovery of metabolites is of particular
relevance for new drugs; that is, NPS whose metabolism is not
well known. Other papers study the degradation of illicit drugs,
after spiked samples have been subjected to processes, such
as hydrolysis, photodegradation, chlorination, biodegradation,
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or any other process of interest (Postigo et al., 2011; Bijlsma
et al., 2013a; Boix et al., 2013, 2014). In all cases, HRMS plays
a key role in the tentative identification of the compounds
formed. Furthermore, the use of specialized software is critical
for a rapid and efficient comparison between the full scan data
set from untreated and treated samples, because manual inspec-
tion of TIC chromatogram to look for visible peaks can easily
fail in complex matrices with low analyte concentrations.
VI. CHIRAL ANALYSIS
The determination of specific metabolic excretion products of
illicit drugs in wastewater is not always possible, and makes
difficult the differentiation between consumption of drugs and
direct disposal of unused drugs. In such situations, chiral
analysis can be applied because most illicit drugs are chiral, and
are subject to stereoselective human metabolism (Emke et al.,
2014; Evans &Kasprzyk-Hordern, 2014).
MDMA (3,4-methylenedioxymethamphetamine) and
MDA (3,4-methylenedioxyamphetamine) profiling in wastewa-
ter is an excellent example of the importance of chiral
enantioselective analysis to distinguish between consumption
and direct disposal of unused MDMA and MDA. Both drugs
have one asymmetric carbon center and therefore they can exist
in the form of two enantiomeric pairs, which differ both
quantitatively and qualitatively in pharmacological activity:
S(þ)-enantiomers are more amphetamine-like stimulants and
R()-enantiomers are more hallucinogenic (Kasprzyk-Hordern
& Baker, 2012a). Both MDMA and MDA have no medical
usage and are synthesized and abused in racemic forms. Their
humanmetabolism is stereoselective and leads to the enrichment
of excreted drugs with their R()-enantiomers. However, if the
presence of MDA in urine is due to MDMA abuse and not direct
MDA use, an enrichment of MDA with S(þ)-enantiomer takes
place (Moore et al., 1996). It is, therefore, expected that after
consumption, both drugs will be present in urine and wastewater
enriched with R()-enantiomers. Indeed, Kasprzyk-Hordern
and Baker (2012a) reported, in a first study of this kind, that
MDMA was enriched with the R()-enantiomer due to prefer-
ential metabolism of S(þ)-MDMA in humans. Furthermore, the
identified MDAwas enriched with S(þ)-enantiomer, to suggest
that its presence might be associated with MDMA consumption
and its subsequent metabolism into S(þ)-MDA and not inten-
tional MDA use (if the latter were true, MDA in wastewater
would be enriched with R()-enantiomer).
Surprisingly, in several instances, during Europe-wide
monitoring undertaken by the SCORE group in 2011–13
(Thomas et al., 2012; Emke et al., 2014; Ort et al., 2014c),
unexpectedly high loads of MDMAwere observed. For example,
in 2011, aberrantly high mass loads of MDMAwere observed in
the wastewater of Utrecht in the Netherlands. These loads highly
deviated from the results observed in the previous monitoring
campaign in 2010 (Bijlsma et al., 2012). Enantiomeric profiling
as shown in Figure 6 revealed that MDMA was racemic
(enantiomeric fraction [EF]¼ 0.54), which indicated its direct
disposal in the sewage system and further explains high loads of
MDMA quantified in Utrecht wastewater during the sampling
week in 2011 (average load was 20-times higher than in 2010).
In contrast, the samples from 2010 (green line in Fig. 6) showed
an average EF of 0.65 that corresponded to excretion profiles in
urine after consumption of MDMA (Emke et al., 2014). This
direct disposal could be the result of a police raid into an illegal
production facility that took place 2 days before the monitoring
started (Emke et al., 2014). The police estimated that 30 kg of
raw MDMA or tablets had been disposed under the pressure of
the police raid.
Enantiomeric profiling of wastewater represents a powerful
tool that allow to determine if mass loads of studied drugs
actually originated from consumption, disposal of unused drugs,
or production waste.
Cellobiohydrolase (CBH) is the most widely used station-
ary phase for enantiomeric profiling of amphetamines with
chiral liquid chromatography coupled with tandem mass spec-
trometry. This cellulase enzyme is immobilized onto 5mm silica
beads with an isoelectric point (pI) of 3.9. It contains multiple
chiral centres and mechanisms for ionic, hydrophobic, and
hydrogen bonding. It has been successfully applied with an
isocratic mobile phase of H2O with 10% 2-propanol and 1mM
NH4OH, to amphetamine-like compounds (Figs. 6 and 7)
(Bagnall et al., 2012; Kasprzyk-Hordern & Baker, 2012a,b;
Emke et al., 2014). There are several factors that have to be
taken into account to achieve satisfactory chiral recognition on
CBH. These are primarily temperature, pH and mobile-phase
composition. Mobile-phase pH plays a key role in chiral
recognition because it influences ionization of both analytes and
CBH. Due to the isoelectric point of 3.9, CBH is negatively
charged at pH>pI, so increasing the mobile phase pH will
facilitate ionic interactions with positively charged analyte (e.g.,
amphetamine or MDMA). This interaction will facilitate longer
retention times and higher enantioselectivity. Hydrophobic
interactions and hydrogen bonding can be influenced with
mobile phases that contain different nature and percentage of
organic modifiers and ionic strength. Less than 20% of organic
modifier is allowed to avoid denaturation of this enzymatic
chiral selector. Lower percentages of organic modifiers lead to
higher retention in the case of amphetamine-like compounds.
Isopropanol, methanol, or acetonitrile are usually used as
organic modifiers. They are characterized by different elution
strengths; for example, methanol has a lower elution strength
than isopropranol. Other factors, which should be considered are
(Camacho-Mu~noz et al., 2016): (i) correct sampling and sample-
preparation protocols that do not introduce stereoselectivity
(e.g., microbial metabolic degradation of analytes might lead to
incorrect estimation of enantiomeric fractions, or use of charged
eluting agents during SPE (e.g., methanol modified with
FIGURE 6. MDMA loads during two separate weeks sampled in 2010 and
2011 in the sewage treatment plant of Utrecht, the Netherlands, and their
corresponding enantiomeric fractions (EF) (Emke et al., 2014).
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ammonium hydroxide) might lead to loss of chiral recognition
in the CBH column), and (ii) elimination of matrix effects (via
robust sample preparation approaches and use of deuterated or
13C-labeled internal standards).
Enantiomeric profiling has been used in WBE as a
complementary tool alongside non-chiral multi-residue methods
that use reversed phase (C18) stationary materials. This addi-
tional analysis required an ad hoc sample preparation, which
meant a higher quantity of sample, and a more time-consuming
and less-cost effective analysis. A recently developed multi-
residue method combined chiral recognition capability of the
CBH-based stationary materials with multi-residue separation
potential of the C18-based materials. The methodology enabled
detection and quantification of all targeted (chiral and non-
chiral) human biomarkers in wastewater along with satisfactory
enantiomeric separations of 18 analytes and a unique single
sample-preparation step (Castrignano, Lubben, & Kasprzyk-
Hordern, 2016).
VII. RELEVANT ANALYTICAL PARAMETERS AND
QUALITY CONTROL
The use of advanced analytical techniques and the expertise of
the analyst are essential to obtain accurate quantitative data for
IDBs in wastewater samples. In addition, appropriate measures
for quality control are required to obtain reliable data.
Obviously, prior to its application, the analytical methodol-
ogy needs to be fully validated for all analytes in terms of
linearity, trueness/accuracy (evaluated by means of recovery
experiments) and precision (as repeatability RSD), selectivity/
specificity, and limits of detection (LOD) and quantification
(LOQ). One of the main drawbacks in this field is the lack of
guidelines specifically directed toward analysis of IDBs in
wastewater. In absence of such guidelines, recommendations in
other fields, such as pesticide residue analysis (SANCO, 2013;
SANTE/11945, 2015), residues in products of animal origin
(European Commission, 2002) bioanalytical methods (EMA,
2012), or clear water act programs (EPA, 2007) can be used as
guidelines.
Commonly, a minimum of 5 replicates are required to
check the accuracy and precision at the targeted LOQ, and at
least one other higher level, for example, 10 times the targeted
LOQ. A quantitative analytical method should be demonstrated
at the initial validation, but also later with sample batches to
perform quality controls (QCs) that provide acceptable recovery
at each spiking level and for each analyte. Acceptable mean
recoveries for IDBs in wastewater are typically in the range 70–
120%, with an associated repeatability RSD 20%, (e.g., as
established for pesticides in SANCO/12571/2013 (SANCO,
2013)).
As previously described in this review, LC-MS systems are
most widely applied in WBE studies. Yet, matrix effects are one
of the main problems associated with the correct determination
of IDBs with these techniques. Matrix effects result from the
competition between matrix co-eluting components and analy-
tes in the ionization process (Trufelli et al., 2011). This
competition affects quantification of the analytes and must,
therefore, be removed, minimized, or corrected for. Quantifica-
tion with matrix-matched calibration is suitable and is fre-
quently used in some research fields, where a representative
blank matrix can be easily obtained. However, the variability of
the chemical composition of wastewater and the common
presence of some compounds in the samples used as “blank”
poses difficulties to use this approach in WBE. Instead, the
standard additions method might be used, but it would imply
many more injections in the LC-MS system, apart from the need
to adjust the additions accordingly to the analyte concentration
in the sample for appropriate application of this methodology.
Furthermore, the high level of some compounds makes it
problematic to maintain linearity in the calibration curve.
Hence, the use of isotope-labeled internal standards (ILIS) is the
most common way to correct for matrix effects, but also for
potential errors associated with sample manipulation and
FIGURE 7. Mass chromatograms show chiral drugs: amphetamine
(AMPH), MDMA, MDA and methamphetamine (METH) in wastewater
obtained with CBH column and HPLC-QqQ MS (modified from Kasprzyk-
Hordern & Baker (2012b)).
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storage if the ILIS is added to the sample just after sample
collection (i.e., as surrogate). When available, the use of a
labeled analyte is recommended to ensure a satisfactory correc-
tion of matrix effects. However, it should be noted that, during
method validation, there is an absolute need to thoroughly
evaluate if the labeled IS accurately corrects for matrix effects.
The estimation of limits of detection (LODs) and limits of
quantification (LOQs) is usually performed based on a signal-
to-noise (s/n) ratio of 1:3 and 1:10, respectively. More-realistic
LOQs can be estimated at s/n 10 for the quantitation transition,
but also at s/n 3 for the qualification transition to ensure not
only the quantification of the compound but also its reliable
identification (Bijlsma et al., 2014a). In Orbitrap data process-
ing, noise is filtered out. Therefore, the common s/n approach
to derive LOQ and LOD does not apply. Instead, LOQs in
Orbitrap MS are determined based on the lowest concentration
of an ILIS in pure water that produces an appreciable signal
that meets the identification criteria (de Voogt et al., 2011;
Bijlsma et al., 2013b). The matrix effect is calculated from the
ratio of the responses of the ILIS in the matrix and in pure
water and used to calculate the actual LOQ in that matrix.
Some guidelines, like SANCO, defined the method LOQ as the
lowest spiking level of the validation that meets the method
performance acceptability—that definition is a stricter criterion
that can also be applied in WBE. Anyway, an estimation of
LODs and LOQs in wastewater is complicated, because notable
variations in chemical composition between samples occur.
Representative matrix-matched standards cannot be easily
prepared, due to the presence of analytes in most influent
samples, and because of the variations in sample composition
from one sample to the other. This fact makes problematic a
rational comparison of these parameters among different
published methodologies. An estimation of LODs/LOQs from
standards in solvent at least could make a fair comparison
between instrumental performances, although not analytical
methods. An efficient and realistic approach to estimate these
parameters in a homogeneous way is from inter-laboratory
exercises where all participants analyze the same samples with
their own analytical methodology.
Confirmation of positives is an essential aspect in the
analysis. To this aim, guidelines such as that from the European
Commission (European Commission, 2002) can be adopted,
where the confirmation of positive findings is based on the
collection of identification points (IPs). The number of IPs
earned depends on the mass analyzer used. Thus, for QqQ low-
resolution instruments used in tandem MS, a minimum of two
transitions should be monitored for a safe positive finding,
whereas in high-resolution instruments at least two ions must be
monitored. In addition, the accomplishment of the ion ratio
between recorded transitions and a retention time within the
maximum tolerances allowed are required.
Not only quantification, but also confirmation of the
identity could be affected by matrix interferences. As stated
before, two transitions (Q, q) are normally acquired in LC-MS/
MS analysis. One of the most-controversial issues is the
accomplishment of the ion ratio between these transitions (q/Q
ratio) required for confirmation. Ion ratios in samples might be
affected by matrix components; for example, when at least one
of the two selected SRM transitions is shared with the matrix,
which might lead to unexpected ion ratios with deviations that
exceed the maximum allowed. This situation is more prone to
happen when the specificity of the neutral losses involved in the
selected transitions is not evaluated and common losses, such as
the loss of H2O or CO2, are implicated. Non-specific transitions
are a weakness not yet tackled with the current guidelines and
should be considered in this research field (Delatour, Mottier, &
Gremaud, 2007). In this situation, the acquisition of all available
transitions is recommended to facilitate confirmation of the
positives by testing the additional transitions acquired. In cases
of non-compliance, the sample might be reported as positive,
but include a comment on the non-compliance of the ratio, and
report the actual q/Q ratio deviation obtained. Additional work
would be necessary to test if any interfering compound actually
affected the q/Q ratio.
During a recent inter-laboratory study undertaken by the
SCORE group, one of the questions raised related to the
significant variations in q/Q ratios reported by the different
participants (Castiglioni et al., 2013), even with the same SRM
transitions. As an example, for cocaine, with 304> 182 (Q) and
304> 82 (q), ion ratios from different laboratories ranged from
0.12 to 0.38, and seemed to notably depend on the instrument
used and on the parameters optimized in each laboratory (e.g.,
cone and collision voltages). In addition, some variations from
batch to batch were also observed. Nevertheless, these variations
were not relevant to confirm identity, because it is recommended
that q/Q ratios are measured and evaluated for accomplishment
by every laboratory within each sample batch with the standards
included in the sequence of sample analysis.
Apart from the validation of the method in each laboratory
before its routine use, the use of internal quality controls (QCs)
is of primary importance to track possible daily method
variations. In theory, an internal QC is a final check of the
correct execution of all the processes that are included in the
analytical protocol. Due to the difficulties to obtain blank
wastewater samples, those with the lowest concentrations
expected are preferred to prepare spiked samples used as
internal QCs. This means that samples from locations with low
drug use and/or collected in the mid-week, where the consump-
tion of illicit drugs is expected to be lower than in the weekends,
would fit better to prepare the QCs. Despite this fact that low
concentrations of IDBs are expected, samples selected should be
analyzed to accurately know the potential analyte concentration
in these “blank” samples, in order to be subtracted from the QC
prepared. Although there is no guideline in this field, QCs
individual recoveries from 60 to 140% might be acceptable in
wastewater analysis, as suggested in the SANCO guidelines
(SANCO, 2013). Other guidelines recommend an acceptable
range of 80–120% at the LOQ level (EMA, 2012). When QC
recoveries are out of this interval, the sample sequence of
analysis should be repeated. If the problem persists, then
appropriate measures should be taken to ensure the accuracy of
the method.
The implementation of quality assurance practices to
analytical chemistry is recognized as a prerequisite to produce
data with known metrological qualities. Regardless of the target
analyte or sample type, quality assurance and quality control are
the cornerstones to analytical data validation. In addition to
daily internal performance verifications via QC materials, a
good quality assurance plan should include regular external
performance evaluations for an independent assessment of
analytical proficiency. The goal of inter-laboratory studies is to
demonstrate that participation in this exercise leads to improved
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quality of analytical results. The results are of crucial interest for
laboratories because these provide clear information of their
measurement capabilities. It has to be pointed out that participa-
tion is either voluntary or forced by external requirements (e.g.,
legal, accreditation, control bodies). Inter-laboratory exercises
involve comparison of participants’ results on a set of spiked
water samples. Care needs to be taken, to ensure concentrations
are equal in all aliquots, especially when particulate matter
should also be analyzed. This also holds true when subsampling
from composite samples (Capel and Larson, 1996). The separate
results are compared with the median of the entire group to
determine the accuracy of the method used. By using a set of
two samples spiked at different levels with the same compound
a so called Youden pair is created. Visualization of these results
in a Youden plot show within- and between-laboratory variabil-
ity. Also individual constant errors become visible, and random
errors and systematical errors can be recognized.
Several inter-laboratory studies have been organized by the
SCORE group on selected IDBs regularly monitored inWBE. In
the period 2011–2015 five consecutive sets of interlaboratory
exercises have been organized, initially with methanolic solu-
tions of analytes that gradually moved to more-complicated
matrices such as extracts and genuine wastewater samples.
These were the first inter-laboratory exercises organized to
determine IDBs in wastewater. The results of this stepwise inter-
laboratory testing and the improvements made during this
5-year period can help to optimize the analytical procedures of
participating laboratories and aid in a reliable interpretation of
WBE data. To this end, concentrations of IDBs in wastewater
provided by laboratories that did not perform well in the
interlaboratory exercises were not taken into account; however,
together with experts in the field, solutions for the analytical
deviations are sought.
VIII. GENERAL SUMMARY AND PERSPECTIVES
The investigation of IDBs in wastewater is a subject of current
interest in analytical chemistry. The complexity of the matrix
under investigation, the low analyte concentrations commonly
found, and the need to detect and quantify not only the parent
compounds but also the main metabolites of drugs, make this
task an analytical challenge. In addition, human metabolism is
not always well known, and the target biomarkers might be
unknown. In this field, liquid chromatography combined with
low- and high-resolution MS is an indispensable tool. Different
strategies can be applied to investigate IDBs in wastewater
(discussed in this review) from quantification of target com-
pounds to the detection and (tentative) identification of unknown
metabolites and TPs.
Quantification of IDBs in wastewater is a requisite in WBE
in order to estimate drug use in populations. However, the
presence of drug residues in wastewater also has other implica-
tions. For example, there is a possible environmental impact
when compounds are not completely removed by WWTPs.
Indeed, low removal rates for certain illicit drugs, such as
MDMA, ketamine, and methadone, have been observed
(Bijlsma et al., 2012). Thus low removal rates implies that drug
residues can be present in effluent wastewater, and finally reach
the aquatic environment. Therefore, the determination of illicit
drugs and metabolites in effluent wastewater and surface water
is also of interest, as well as the investigation of potential TPs
that can be formed in the environment. Here, concentration
levels are much lower than in influent wastewater and, therefore,
excellent sensitivity is required for the analytical methods.
In this field, under continuous development, several trends
and needs can be highlighted:
1. There is a need to increase the knowledge of metabolites
that might be present in the aquatic environment.
Especially for NPS, there is a lack of metabolism studies,
and target compounds are still not fully identified. Here,
the use of HRMS is highly promising due to its potential
to detect and identify drug-related compounds to make
use of different approaches, such as the “common
fragmentation pathway,” which is very useful to find
parent-chemically related compounds. Advantageously, a
retrospective analysis can be made at any time from
HRMS data to facilitate the search of compounds of
interest (e.g., new discovered metabolites) in samples
previously analyzed. Furthermore, from the perspective
of environmental chemistry, it is of interest to extend this
research to TPs, which in many occasions are still
unknown.
2. The development of wide-scope screening will surely be
one of the key features of HRMS in the next few years.
The use of long lists of selected compounds is essential to
facilitate target screening with or without (suspect
screening) reference standards. To maintain the “univer-
sality” of this approach, generic sample treatments would
be required in order to avoid potential losses of analytes
during sample handling. Some problematic compounds,
mainly those present in ionic form, will always require
specific/individual methods, because they cannot be
included in multi-residue/multi-class methodologies, due
to their special physico-chemical characteristics.
3. In line with the previous point, it is expected to widen
future screening to include NPS. However, it will not be
easy to obtain satisfactory results in this case because
of two main limitations: (i) very low concentrations
expected in the samples as a consequence of the limited
use of these compounds in comparison with “conven-
tional” drugs, such as cocaine, cannabis, or amphet-
amines; (ii) continuous appearance of new NPS with
changes in the chemical structure that complicate their
detection and identification. Related to the last point,
HRMS will be a powerful tool to identify NPS and
unknown metabolites.
4. The combination of non-biased and biased non-target
analysiswith HRMS will be one of the key research fields
in the near future. Hopefully, this combined approach
will allow one to discover new compounds of interest,
such as unknown or non-searched metabolites, TPs and/
or new drugs. Their low concentrations in most cases will
be an extra difficulty to obtain satisfactory results.
5. LC-MS/MS with triple quadrupole mass analyzers will
still be the reference technique to quantify selected IDBs
in target methodologies, due to its excellent sensitivity
and selectivity. However, new instruments with improved
performances will widen the number of compounds
included in the method up to several hundreds. The
incomparable sensitivity reached with this instrumentation
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will obtain data on the presence of NPS in wastewaters,
with expected concentrations at the pg/L level.
6. A common protocol of action should be used in WBE
studies to produce homogeneous and comparable data at
different sites and provide the most reliable estimates of
drug use. Uncertainty factors associated with the differ-
ent steps involved in WBE (sampling, chemical analysis,
stability of drug biomarkers in sewage, back-calculation
of drug use, estimation of population size) have to be
considered in order to minimize the uncertainty of the
entire procedure (Castiglioni et al., 2013). A best practice
protocol has been recently proposed and adopted by
Europe-wide studies. Three phases of the approach are
included: sampling and sample handling, storage treat-
ment during sampling, chemical analysis-quality control
(EMCDDA, 2016). Currently, the most-urgent needs for
future research are: (i) improve the quality of chemical
analyses by following specific quality requirements; (ii)
improve the knowledge on stability of IDBs in-sewer;
(iii) plan additional pharmacokinetic studies to produce
reliable human excretion profiles for IDBs; (iv) explore
novel possibilities to estimate the population size in a
catchment.
7. The improved characteristics of HRMS instruments,
mainly sensitivity and linear dynamic range, will make
this technique attractive for quantitative analysis as well.
The search for the desired “All-in-One” method and
instrument will still continue in the coming years,
because combination of all desired features in just one
method/instrument is an exciting issue: qualitative and
quantitative analysis, with possibilities for structural
elucidation of unknowns. Future developments of HRMS
will surely be related to scan-speed improvements for
Orbitrap, which for example will allow more efficient
combination to UHPLC, or GC, whereas improvements
in TOF MS analyzers will increase the mass-resolving
power. Advances will include development of tribrid
analyzers that incorporate new possibilities such as Ion
Mobility Spectrometry. Improvements in accurate-mass
full-acquisition data processing with more-powerful and
user-friendly software are also expected. In the near
future, we will see a growth of HRMS applications, not
only inWBE, but also in other fields, such as environmen-
tal research, food-safety, toxicology and doping control
analysis.
8. It will be necessary to harmonize the criteria for reliable
identification/confirmation of compounds detected in
samples. Relevant parameters, as the number and speci-
ficity of ions required, maximum ion-ratio deviations
allowed, mass errors accepted are needed to facilitate
comparison of data and to avoid false positives or
negatives due to the use of dissimilar criteria among
different authors.
9. The limits of detection and/or quantification of the
methods is a requisite to perform realistic comparison of
data in WBE studies. The non-detection might be
translated to figures that depend on the LOD; that is, the
method sensitivity. The comparison of drug consumption
among populations makes use in some occasions of very
low concentration data for less-consumed drugs; this
comparison might be distorted with unrealistic LOD/
LOQ data. There is a need to harmonize criteria for their
estimation inWBE.
10. Further development of chiral analytical methods and
wider application of enantiomeric profiling of wastewater
are expected in the coming years. This expectation is
because enantiomeric profiling of illicit/abused drugs in
wastewater represents a powerful tool to allow one to
differentiate between consumption and disposal of un-
used drugs or production waste in WBE. Advances are
needed in the design of new, more-robust stationary
materials to separate multi-residue mixtures of chiral
drugs within a shorter method time.
11. A wastewater validation guideline, based on the existing
guidelines, is desired including key aspects related to
quality control that must be carefully considered in
WBE. Internal and external quality controls are both
needed for a reliable analytical methodology. The
organization of interlaboratory exercises are imperative
from two perspectives: (i) to produce reliable WBE data,
and (ii) to improve analytical performance of participat-
ing laboratories.
12. The ultimate goal of WBE is to provide results in real-
time. This data can be achieved with biosensors. Bio-
sensors have already been applied inWBE to screen PSA,
prostate cancer biomarker (Yang et al., 2015c), DNA
(Yang et al., 2015a), and cocaine (Yang et al., 2016).
There are, however, several issues that need to be
addressed; mainly the relatively low sensitivity of bio-
sensors and most probably low selectivity. Due to fast
advancements in the field, wide application of biosensors
inWBE is envisaged (Yang et al., 2015b).
13. The potential of WBEwill be expanded to other aspects of
public health. Sewage contains a hidden wealth of highly
complex chemical information about biological processes
that occur in the human body (Daughton, 2011). Specific
biomarkers could serve as indicators of exposure, stress,
vulnerability to disease, acquired disease, or health.
Biomarkers include endogenous compounds produced in
response to stress or indicative of health, adducts of
endogenous chemicals and xenobiotics, or metabolites of
detoxification or intoxication processes from xenobiotic
exposure (Daughton, 2012). Theoretically, such biomark-
ers could serve as collective measures of community-
wide health or disease, and could provide a means to
conduct epidemiology in near-real time. It has, therefore,
the capability to serve as an early-warning system in
pandemics (Ort et al., 2014a). Quantitative analysis of
“health biomarkers” in sewage might allow one to
monitor changes over time; for example, in response to
specific campaigns, identification of trends and, inter-
community comparisons in relation to their health, diet,
lifestyle, and environment (Thomas & Reid, 2011).
14. It is essential to widen the knowledge on selection of the
most-appropriate IDB in WBE and to take into account
specific requirements that a proper biomarker should
fulfil in order to ensure the reliability of the back-
calculated estimates. The main requirements for an IDB
are: (i) excretion in consistent amounts in urine; (ii)
detectable in urban wastewater; (iii) stable in wastewater;
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(iv) human excretion as unique source. These character-
istics are essential to perform a reliable quantitative
analysis of the substance under investigation and should







EMCDDA European Monitoring Centre for Drugs and Drug
Addiction
ESI electrospray ionization
GC-MS gas chromatography coupled to mass spectro-
metry
HE high collision energy
HRMS high-resolution mass spectrometry
IDB illicit drug biomarker
ILIS isotope-labeled internal standards
IP identification point
LC-MS liquid chromatography coupled to mass spectro-
metry
LC-MS/MS liquid chromatography coupled to tandem mass
spectrometry
LE low collision energy
LOD limits of detection
LOQ limits of quantification
LRMS low-resolution mass spectrometry
MDA 3,4-methylenedioxyamphetamine
MDMA 3,4-methylenedioxymethamphetamine
NPS new psychoactive substances
QC quality control
QqQ triple quadrupole analyzer
QSRRs quantitative structure-retention relationships
SCORE sewage analysis CORe group Europe
SDL screening detection limit
SIM selected ion monitoring
s/n signal-to-noise
SRM selected reaction monitoring
TIC total ion chromatogram
TPs transformation products
tR retention time
UHPLC ultra-high performance liquid chromatography
WBE wastewater-based epidemiology
WWTP wastewater treatment plant
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